T5SS: Total 5-symptom score.

1. Bousquet J, Bachert C, Canonica GW, et al. Efficacy of desloratadine in intermittent allergic rhinitis: a GA2LEN study. Allergy. 2009;64(10):151623.

The mean reduction in AM/PM reflective T5SS was significantly greater with Aerius than placebo over days 1–29.¹


 

T5SS: Total 5-symptom score.

1. Bousquet J, Bachert C, Canonica GW, et al. Efficacy of desloratadine in intermittent allergic rhinitis: a GA2LEN study. Allergy. 2009;64(10):151623.

The mean reduction of AM/PM reflective T5SS was significantly greater with Aerius than with placebo over 15 days.¹
 

T5SS: Total 5-symptom score.
 

1. Bousquet J, Bachert C, Canonica GW, et al. Efficacy of desloratadine in intermittent allergic rhinitis: a GA2LEN study. Allergy. 2009;64(10):151623.

Treatment with Aerius tablets improved sleep quality in AR patients.¹
 

Aerius significantly reduced sleep problems in AR patients by 32% at Day 14.¹
 

AR: Allergic rhinitis
1. Aerius^TM Tablet PIL.
2. Pradalier A, Neukirch C, Dreyfus I, Devillier P. Desloratadine improves quality of life and symptom severity in patients with allergic rhinitis. Allergy. 2007;62(11):133134.

Aerius significantly decreased subjects’ overall condition (combined score for itching and number of hives) by 48% at Day 14.¹

Treatment with Aerius resulted in moderate, marked, or complete relief of symptoms in 76.2% of subjects.¹



1. Kim H, Lynde C. Impact of Desloratadine on Symptoms and Quality of Life in Subjects with Chronic Idiopathic Urticaria: A Multicenter, Practicebased Study. Archives of Drug Information. 2008;1(2):639.

CLINICALS

Aerius^TM

PATIENTS

98.5% of patients rated the tolerability of Aerius^TM as "good" or "excellent."¹

DOSAGE:¹
ADULTS AND ADOLESCENTS 
12 YEARS OF AGE AND OLDER:

ONE TABLET ONCE DAILY.



1. AeriusTM Tablet PIL.

1. In intermittent allergic rhinitis, Aerius^TM shows significantly greater reduction in the mean of AM/PM reflective T5SS vs. placebo.¹
2. In persistent allergic rhinitis, Aerius^TM shows significantly greater reduction in the mean AM/PM reflective T5SS vs. placebo.²
3. Aerius^TM significantly improved sleep quality in AR patients.³
4. Aerius^TM has a favorable tolerability profile.⁴

T5SS=total 5 symptom score, AR=allergic rhinitis

1. Bousquet J, Bachert C, Canonica GW, et al. Efficacy of desloratadine in intermittent allergic rhinitis: a GA2LEN study. Allergy. 2009;64(10):151623.
2. Bousquet J, Bachert C, Canonica GW, et al. Efficacy of desloratadine in persistent allergic rhinitis–a GA2LEN study. International Archives of Allergy and Immunology. 2010;153(4):395402.
3. AeriusTM Tablet PIL.
4. Bachert C, Maurer M. Safety and efficacy of desloratadine in subjects with seasonal allergic rhinitis or chronic urticaria. Clinical Drug Investigation. 2010;30(2):10922.